GBA1 and synucleinopathy: In addition, heterozygous GbaWT/D409V mice also harbor these aggregates, but to a lesser degree, suggesting a gene-dosage effect similar to the human condition, where synucleinopathy risk is higher in homozygous GBA mutation carriers than for heterozygotes [23].